Lymphocyte mitochondria: Toward identification of peripheral biomarkers in the progression of Alzheimer disease

Free Radical Biology and Medicine

Volumn 65, Issue , 2013, Pages 595-606

  Sultana, Rukhsana ^a   Baglioni, Mauro ^b   Cecchetti, Roberta ^b   Cai, Jian ^c   Klein, Jon B ^c   Bastiani, Patrizia ^b   Ruggiero, Carmelinda ^b   Mecocci, Patrizia ^b   Butterfield, D Allan ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF PERUGIA   (Italy)

^c University of Louisville School of Medicine   (United States)

Author keywords

Alzheimer disease; Free radicals; Lymphocytes; Mild cognitive impairment; Mitochondria; Oxidative stress; Peripheral biomarker; Proteomics

Indexed keywords

ALPHA TOCOPHEROL; BETA CAROTENE; BIOLOGICAL MARKER; MYOSIN LIGHT CHAIN; MYOSIN LIGHT POLYPEPTIDE 6; PEROXIREDOXIN 3; POLYPEPTIDE; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE BETA; UNCLASSIFIED DRUG;

AGED; ALZHEIMER DISEASE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HUMAN; LYMPHOCYTE; MALE; MASS SPECTROMETRY; MILD COGNITIVE IMPAIRMENT; MINI MENTAL STATE EXAMINATION; MITOCHONDRION; OXIDATIVE STRESS; PATHOGENESIS; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEOMICS; WESTERN BLOTTING; ISOELECTRIC FOCUSING; METABOLISM; PHYSIOLOGY; TWO DIMENSIONAL GEL ELECTROPHORESIS; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; BIOMARKERS; DISEASE PROGRESSION; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FEMALE; HUMANS; ISOELECTRIC FOCUSING; LYMPHOCYTES; MALE; MASS SPECTROMETRY; MILD COGNITIVE IMPAIRMENT; MITOCHONDRIA; OXIDATIVE STRESS; PROTEOMICS;

EID: 84884528242     PISSN: 08915849     EISSN: 18734596     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2013.08.001     Document Type: Article

References (66)

1. K. Gustaw-Rothenberg, A. Lerner, D.J. Bonda, H.G. Lee, X. Zhu, G. Perry, and M.A. Smith Biomarkers in Alzheimer's disease: past, present and future Biomarkers Med. 4 2010 15 26
2. L.E. Hebert, P.A. Scherr, J.L. Bienias, D.A. Bennett, and D.A. Evans Alzheimer disease in the US population: prevalence estimates using the 2000 census Arch. Neurol. 60 2003 1119 1122 (Pubitemid 36975801)
3. S.I. Rapoport In vivo PET imaging and postmortem studies suggest potentially reversible and irreversible stages of brain metabolic failure in Alzheimer's disease Eur. Arch. Psychiatry Clin. Neurosci 249 Suppl. 3 1999 46 55
4. N.C. Fox, W.R. Crum, R.I. Scahill, J.M. Stevens, J.C. Janssen, and M.N. Rossor Imaging of onset and progression of Alzheimer's disease with voxel-compression mapping of serial magnetic resonance images Lancet 358 2001 201 205 (Pubitemid 32718544)
5. D.J. Selkoe Alzheimer's disease: genes, proteins, and therapy Physiol. Rev. 81 2001 741 766 (Pubitemid 32267077)
6. D. Boyd-Kimball, H. Mohmmad Abdul, T. Reed, R. Sultana, and D.A. Butterfield Role of phenylalanine 20 in Alzheimer's amyloid beta-peptide (1-42)-induced oxidative stress and neurotoxicity Chem. Res. Toxicol. 17 2004 1743 1749 (Pubitemid 39665568)
7. D. Boyd-Kimball, R. Sultana, H.F. Poon, B.C. Lynn, F. Casamenti, G. Pepeu, J.B. Klein, and D.A. Butterfield Proteomic identification of proteins specifically oxidized by intracerebral injection of amyloid beta-peptide (1-42) into rat brain: implications for Alzheimer's disease Neuroscience 132 2005 313 324 (Pubitemid 40417906)
8. D.A. Butterfield, and D. Boyd-Kimball The critical role of methionine 35 in Alzheimer's amyloid beta-peptide (1-42)-induced oxidative stress and neurotoxicity Biochim. Biophys. Acta 1703 2005 149 156 (Pubitemid 40170438)
9. D.A. Butterfield, V. Galvan, M.B. Lange, H. Tang, R.A. Sowell, P. Spilman, J. Fombonne, O. Gorostiza, J. Zhang, R. Sultana, and D.E. Bredesen In vivo oxidative stress in brain of Alzheimer disease transgenic mice: requirement for methionine 35 in amyloid β-peptide of APP Free Radic. Biol. Med. 48 2010 136 144
10. W.R. Markesbery Oxidative stress hypothesis in Alzheimer's disease Free Radic. Biol. Med. 23 1997 134 147 (Pubitemid 27217017)
11. M. Fukuda, F. Kanou, N. Shimada, M. Sawabe, Y. Saito, S. Murayama, M. Hashimoto, N. Maruyama, and A. Ishigami Elevated levels of 4-hydroxynonenal- histidine Michael adduct in the hippocampi of patients with Alzheimer's disease Biomed. Res. 30 2009 227 233
12. W.R. Markesbery, and M.A. Lovell 4-Hydroxynonenal, a product of lipid peroxidation, is increased in the brain in Alzheimer's disease Neurobiol. Aging 19 1998 33 36 (Pubitemid 28167792)
13. P. Mecocci, M.C. Polidori, A. Cherubini, T. Ingegni, P. Mattioli, M. Catani, P. Rinaldi, R. Cecchetti, W. Stahl, U. Senin, and M.F. Beal Lymphocyte oxidative DNA damage and plasma antioxidants in Alzheimer disease Arch. Neurol. 59 2002 794 798 (Pubitemid 34517762)
14. K.S. Montine, S.J. Olson, V. Amarnath, W.O. Whetsell Jr, D.G. Graham, and T.J. Montine Immunohistochemical detection of 4-hydroxy-2-nonenal adducts in Alzheimer's disease is associated with inheritance of APOE4 Am. J. Pathol. 150 1997 437 443 (Pubitemid 27073773)
15. D. Pratico, and S. Sung Lipid peroxidation and oxidative imbalance: early functional events in Alzheimer's disease J. Alzheimers Dis. 6 2004 171 175 (Pubitemid 38560253)
16. W. Volkel, T. Sicilia, A. Pahler, W. Gsell, T. Tatschner, K. Jellinger, F. Leblhuber, P. Riederer, W.K. Lutz, and M.E. Gotz Increased brain levels of 4-hydroxy-2-nonenal glutathione conjugates in severe Alzheimer's disease Neurochem. Int. 48 2006 679 686
17. K. Hensley, M.L. Maidt, Z. Yu, H. Sang, W.R. Markesbery, and R.A. Floyd Electrochemical analysis of protein nitrotyrosine and dityrosine in the Alzheimer brain indicates region-specific accumulation J. Neurosci. 18 1998 8126 8132 (Pubitemid 28464991)
18. C.M. Lauderback, J.M. Hackett, F.F. Huang, J.N. Keller, L.I. Szweda, W.R. Markesbery, and D.A. Butterfield The glial glutamate transporter, GLT-1, is oxidatively modified by 4-hydroxy-2-nonenal in the Alzheimer's disease brain: the role of Abeta1-42 J. Neurochem. 78 2001 413 416 (Pubitemid 32664423)
19. P.I. Moreira, A. Nunomura, M. Nakamura, A. Takeda, J.C. Shenk, G. Aliev, M.A. Smith, and G. Perry Nucleic acid oxidation in Alzheimer disease Free Radic. Biol. Med. 44 2008 1493 1505
20. A. Nunomura, T. Tamaoki, K. Tanaka, N. Motohashi, M. Nakamura, T. Hayashi, H. Yamaguchi, S. Shimohama, H.G. Lee, X. Zhu, M.A. Smith, and G. Perry Intraneuronal amyloid beta accumulation and oxidative damage to nucleic acids in Alzheimer disease Neurobiol. Dis. 37 2010 731 737
21. C. Caspersen, N. Wang, J. Yao, A. Sosunov, X. Chen, J.W. Lustbader, H.W. Xu, D. Stern, G. McKhann, and S.D. Yan Mitochondrial Abeta: a potential focal point for neuronal metabolic dysfunction in Alzheimer's disease FASEB J 19 2005 2040 2041 (Pubitemid 41759758)
22. P.H. Reddy Amyloid beta, mitochondrial structural and functional dynamics in Alzheimer's disease Exp. Neurol. 218 2009 286 292
23. R. Sultana, and D.A. Butterfield Oxidatively modified, mitochondria-relevant brain proteins in subjects with Alzheimer disease and mild cognitive impairment J. Bioenerg. Biomembr. 41 2009 441 446
24. M. Ankarcrona, F. Mangialasche, and B. Winblad Rethinking Alzheimer's disease therapy: are mitochondria the key? J. Alzheimers Dis. 20 Suppl. 2 2010 S579 590
25. R. Sultana, P. Mecocci, F. Mangialasche, R. Cecchetti, M. Baglioni, and D.A. Butterfield Increased protein and lipid oxidative damage in mitochondria isolated from lymphocytes from patients with Alzheimer's disease: insights into the role of oxidative stress in Alzheimer's disease and initial investigations into a potential biomarker for this dementing disorder J. Alzheimers Dis 24 2011 77 84
26. F. Mangialasche, W. Xu, M. Kivipelto, E. Costanzi, S. Ercolani, M. Pigliautile, R. Cecchetti, M. Baglioni, A. Simmons, H. Soininen, M. Tsolaki, I. Kloszewska, B. Vellas, S. Lovestone, and P. Mecocci Tocopherols and tocotrienols plasma levels are associated with cognitive impairment Neurobiol. Aging. 33 2012 2282 2290
27. F. Pallotti, and G. Lenaz Isolation and subfractionation of mitochondria from animal cells and tissue culture lines Methods Cell Biol 80 2007 3 44
28. R. Sultana, A. Ravagna, H. Mohmmad-Abdul, V. Calabrese, and D.A. Butterfield Ferulic acid ethyl ester protects neurons against amyloid beta-peptide(1-42)-induced oxidative stress and neurotoxicity: relationship to antioxidant activity J. Neurochem. 92 2005 749 758 (Pubitemid 40229546)
29. M.Y. Aksenov, M.V. Aksenova, D.A. Butterfield, J.W. Geddes, and W.R. Markesbery Protein oxidation in the brain in Alzheimer's disease Neuroscience 103 2001 373 383 (Pubitemid 32201924)
30. D.A. Butterfield, T.T. Reed, M. Perluigi, C. De Marco, R. Coccia, J.N. Keller, W.R. Markesbery, and R. Sultana Elevated levels of 3-nitrotyrosine in brain from subjects with amnestic mild cognitive impairment: implications for the role of nitration in the progression of Alzheimer's disease Brain Res. 1148 2007 243 248 (Pubitemid 46602178)
31. R. Sultana, D. Boyd-Kimball, J. Cai, W.M. Pierce, J.B. Klein, M. Merchant, and D.A. Butterfield Proteomics analysis of the Alzheimer's disease hippocampal proteome J. Alzheimers Dis. 11 2007 153 164 (Pubitemid 47010980)
32. D.A. Butterfield, and E.R. Stadtman Protein oxidation processes in aging brain Adv. Cell Aging Gerontol 2 1997 161 191
33. D.A. Butterfield, T. Reed, M. Perluigi, C. De Marco, R. Coccia, C. Cini, and R. Sultana Elevated protein-bound levels of the lipid peroxidation product, 4-hydroxy-2-nonenal, in brain from persons with mild cognitive impairment Neurosci. Lett. 397 2006 170 173
34. K.S. Williamson, S.P. Gabbita, S. Mou, M. West, Q.N. Pye, W.R. Markesbery, R.V. Cooney, P. Grammas, U. Reimann-Philipp, R.A. Floyd, and K. Hensley The nitration product 5-nitro-γ-tocopherol is increased in the Alzheimer brain Nitric Oxide 6 2002 221 227 (Pubitemid 34848445)
35. M. Manczak, T.S. Anekonda, E. Henson, B.S. Park, J. Quinn, and P.H. Reddy Mitochondria are a direct site of A beta accumulation in Alzheimer's disease neurons: implications for free radical generation and oxidative damage in disease progression Hum. Mol. Genet 15 2006 1437 1449
36. D.A. Butterfield, and R. Sultana Methionine-35 of Abeta(1-42): importance for oxidative stress in Alzheimer disease J. Amino Acids. 2011 2011 198430
37. D.A. Butterfield, M.L. Bader Lange, and R. Sultana Involvements of the lipid peroxidation product, HNE, in the pathogenesis and progression of Alzheimer's disease Biochim. Biophys. Acta 1801 2010 924 929
38. F.J. Jimenez-Jimenez, J.A. Molina, F. de Bustos, M. Orti-Pareja, J. Benito-Leon, A. Tallon-Barranco, T. Gasalla, J. Porta, and J. Arenas Serum levels of beta-carotene, alpha-carotene and vitamin A in patients with Alzheimer's disease Eur. J. Neurol. 6 1999 495 497 (Pubitemid 29371150)
39. Z. Zaman, S. Roche, P. Fielden, P.G. Frost, D.C. Niriella, and A.C. Cayley Plasma concentrations of vitamins A and E and carotenoids in Alzheimer's disease Age Ageing 21 1992 91 94
40. E. Parks, and M.G. Traber Mechanisms of vitamin E regulation: research over the past decade and focus on the future Antioxid. Redox Signaling 2 2000 405 412
41. S. Sung, Y. Yao, K. Uryu, H. Yang, V.M. Lee, J.Q. Trojanowski, and D. Pratico Early vitamin E supplementation in young but not aged mice reduces Abeta levels and amyloid deposition in a transgenic model of Alzheimer's disease FASEB J 18 2004 323 325
42. N. Farina, M.G. Isaac, A.R. Clark, J. Rusted, and N. Tabet Vitamin E for Alzheimer's dementia and mild cognitive impairment Cochrane Database Syst. Rev. 11 2012 CD002854
43. K. Hensley, L.L. Barnes, A. Christov, C. Tangney, W.G. Honer, J.A. Schneider, D.A. Bennett, and M.C. Morris Analysis of postmortem ventricular cerebrospinal fluid from patients with and without dementia indicates association of vitamin E with neuritic plaques and specific measures of cognitive performance J. Alzheimers Dis. 24 2011 767 774
44. A.J. Perkins, H.C. Hendrie, C.M. Callahan, S. Gao, F.W. Unverzagt, Y. Xu, K.S. Hall, and S.L. Hui Association of antioxidants with memory in a multiethnic elderly sample using the Third National Health and Nutrition Examination Survey Am. J. Epidemiol. 150 1999 37 44 (Pubitemid 29297266)
45. P. Rinaldi, M.C. Polidori, A. Metastasio, E. Mariani, P. Mattioli, A. Cherubini, M. Catani, R. Cecchetti, U. Senin, and P. Mecocci Plasma antioxidants are similarly depleted in mild cognitive impairment and in Alzheimer's disease Neurobiol. Aging 24 2003 915 919 (Pubitemid 36962976)
46. M. Sano, C. Ernesto, R.G. Thomas, M.R. Klauber, K. Schafer, M. Grundman, P. Woodbury, J. Growdon, C.W. Cotman, E. Pfeiffer, L.S. Schneider, and L.J. Thal A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease: the Alzheimer's Disease Cooperative Study N. Engl. J. Med. 336 1997 1216 1222 (Pubitemid 27183651)
47. D.R. Galasko, E. Peskind, C.M. Clark, J.F. Quinn, J.M. Ringman, G.A. Jicha, C. Cotman, B. Cottrell, T.J. Montine, R.G. Thomas, and P. Aisen Antioxidants for Alzheimer disease: a randomized clinical trial with cerebrospinal fluid biomarker measures Arch. Neurol. 69 2012 836 841
48. Y.J. Suzuki, M. Tsuchiya, S.R. Wassall, Y.M. Choo, G. Govil, V.E. Kagan, and L. Packer Structural and dynamic membrane properties of alpha-tocopherol and alpha-tocotrienol: implication to the molecular mechanism of their antioxidant potency Biochemistry 32 1993 10692 10699 (Pubitemid 23327802)
49. S. Christen, A.A. Woodall, M.K. Shigenaga, P.T. Southwell-Keely, M.W. Duncan, and B.N. Ames gamma-Tocopherol traps mutagenic electrophiles such as NO(X) and complements alpha-tocopherol: physiological implications Proc. Natl. Acad. Sci. USA 94 1997 3217 3222
50. E. Niki Tocopherylquinone and tocopherylhydroquinone Redox Rep. 12 2007 204 210 (Pubitemid 350065107)
51. A. Castegna, V. Thongboonkerd, J.B. Klein, B. Lynn, W.R. Markesbery, and D.A. Butterfield Proteomic identification of nitrated proteins in Alzheimer's disease brain J. Neurochem. 85 2003 1394 1401 (Pubitemid 36702552)
52. A. Castegna, M. Aksenov, V. Thongboonkerd, J.B. Klein, W.M. Pierce, R. Booze, W.R. Markesbery, and D.A. Butterfield Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part II. Dihydropyrimidinase-related protein 2, alpha-enolase and heat shock cognate 71 J. Neurochem. 82 2002 1524 1532
53. A. Castegna, M. Aksenov, M. Aksenova, V. Thongboonkerd, J.B. Klein, W.M. Pierce, R. Booze, W.R. Markesbery, and D.A. Butterfield Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part I. Creatine kinase BB, glutamine synthase, and ubiquitin carboxy-terminal hydrolase L-1 Free Radic. Biol. Med. 33 2002 562 571 (Pubitemid 34874977)
54. J. Choi, A.I. Levey, S.T. Weintraub, H.D. Rees, M. Gearing, L.S. Chin, and L. Li Oxidative modifications and down-regulation of ubiquitin carboxyl-terminal hydrolase L1 associated with idiopathic Parkinson's and Alzheimer's diseases J. Biol. Chem. 279 2004 13256 13264 (Pubitemid 38445905)
55. R. Sultana, H.F. Poon, J. Cai, W.M. Pierce, M. Merchant, J.B. Klein, W.R. Markesbery, and D.A. Butterfield Identification of nitrated proteins in Alzheimer's disease brain using a redox proteomics approach Neurobiol. Dis. 22 2006 76 87
56. R. Sultana, and D.A. Butterfield Role of oxidative stress in the progression of Alzheimer's disease J. Alzheimers Dis. 19 2010 341 353
57. D.A. Butterfield, S.S. Hardas, and M.L. Lange Oxidatively modified glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and Alzheimer's disease: many pathways to neurodegeneration J. Alzheimers Dis. 20 2010 369 393
58. M. Takano, T. Yamashita, K. Nagano, M. Otani, K. Maekura, H. Kamada, S. Tsunoda, Y. Tsutsumi, T. Tomiyama, H. Mori, K. Matsuura, and S. Matsuyama Proteomic analysis of the hippocampus in Alzheimer's disease model mice by using two-dimensional fluorescence difference in gel electrophoresis Neurosci. Lett. 534 2013 85 89
59. H.L. Tang, H.L. Lung, K.C. Wu, A.H. Le, H.M. Tang, and M.C. Fung Vimentin supports mitochondrial morphology and organization Biochem. J. 410 2008 141 146 (Pubitemid 351300333)
60. J. Fujii, and Y. Ikeda Advances in our understanding of peroxiredoxin, a multifunctional, mammalian redox protein Redox Rep. 7 2002 123 130 (Pubitemid 34700435)
61. 2-dependent, reversible inactivation of peroxiredoxin III in mitochondria Mol. Cell 46 2012 584 594
62. 2 removal in brain mitochondria via the thioredoxin/peroxiredoxin system J. Biol. Chem. 285 2010 27850 27858
63. P. Lopert, B.J. Day, and M. Patel Thioredoxin reductase deficiency potentiates oxidative stress, mitochondrial dysfunction and cell death in dopaminergic cells PLoS One 7 2012 e50683
64. S.H. Kim, M. Fountoulakis, N. Cairns, and G. Lubec Protein levels of human peroxiredoxin subtypes in brains of patients with Alzheimer's disease and Down syndrome J. Neural Transm. Suppl. 61 2001 223 235 (Pubitemid 38085085)
65. T.S. Chang, C.S. Cho, S. Park, S. Yu, S.W. Kang, and S.G. Rhee Peroxiredoxin III, a mitochondrion-specific peroxidase, regulates apoptotic signaling by mitochondria J. Biol. Chem. 279 2004 41975 41984 (Pubitemid 39313648)
66. V. Calabrese, R. Sultana, G. Scapagnini, E. Guagliano, M. Sapienza, R. Bella, J. Kanski, G. Pennisi, C. Mancuso, A.M. Stella, and D.A. Butterfield Nitrosative stress, cellular stress response, and thiol homeostasis in patients with Alzheimer's disease Antioxid. Redox Signaling 8 2006 1975 1986 (Pubitemid 46489625)